Neoadjuvant chemotherapy is increasingly used in breast cancer, especially for
downstaging the primary tumor in the breast and the metastatic axillary lymph node …

Diffusion‐weighted imaging (DWI) is increasingly being incorporated into routine breast MRI
protocols in many institutions worldwide, and there are abundant breast DWI indications …

The goals of imaging after neoadjuvant therapy for breast cancer are to monitor the
response to therapy and facilitate surgical planning. MRI has been found to be more …

This review aims to identify factors causing heterogeneity in breast DWI–MRI and their
impact on its value for identifying breast cancer patients with pathological complete …

Objective Apparent diffusion coefficient (ADC) values derived from Diffusion-weighted
images are able to reflect tumor microstructure, such as cellularity, extracellular matrix or …

Background Amide proton transfer‐weighted imaging (APTWI) and intravoxel incoherent
motion imaging (IVIM) are valuable MRI techniques applied to cancer. Purpose To compare …

The role of diffusion weighted imaging (DWI) as a biomarker has been the subject of active
investigation in the field of breast radiology. By quantifying the random motion of water …

Neoadjuvant chemotherapy (NAC) is increasingly widely used in breast cancer treatment,
and accurate evaluation of its response provides essential information for treatment and …

A multiparametric approach to breast cancer imaging offers the advantage of integrating the
diverse contributions of various parameters. Dynamic contrast-enhanced magnetic …

Background To investigate the performance of diffusion-weighted (DW) MRI with mono-, bi-
and stretched-exponential models in predicting pathologic complete response (pCR) to …